The ER, often described as the cell’s protein factory, is responsible for the maturation, folding, and trafficking of a vast array of proteins. Unlike other organelles such as mitochondria, where an abundance of reduced glutathione (GSH) preserves a reductive environment, the ER requires an oxidizing milieu to facilitate the formation of disulfide bonds critical for protein structural integrity. Maintaining this delicate redox balance has long been known as essential, yet the specific molecular systems regulating glutathione transport in and out of the ER remained elusive—until now.

Harnessing a novel liposome-based assay developed by postdoctoral researcher Shanshan Liu and Ph.D. candidate Mark Gad, the team led by Kivanç Birsoy was able to characterize the transport activity of SLC33A1 with unprecedented precision. This transporter effectively imports oxidized glutathione (GSSG) into the ER while exporting the reduced variant (GSH), thereby fine-tuning the oxidative ratio inside the lumen. Their innovative methodological approach combined with genetic and structural analyses provided compelling evidence that SLC33A1 is the gatekeeper controlling glutathione redox balance within the ER.

This redox balance is not merely a bystander in cellular homeostasis but a fundamental determinant of protein folding quality control. The research indicates that the ER’s proofreading machinery, which ensures proteins achieve their correct conformation before export to the cytosol, depends critically on the appropriate glutathione ratio. When GSSG accumulates excessively due to dysfunctional SLC33A1 activity, this inhibits enzymes required for proper disulfide bond formation and quality control, resulting in protein misfolding and aggregation within the ER.

Persistent accumulation of misfolded proteins triggers a cellular stress response and, if unresolved, leads to cell death. Such dysregulation has been linked to myriad pathologies, underscoring the clinical significance of maintaining ER redox homeostasis. The team’s findings illuminate how mutations in SLC33A1 disrupt this glutathione transport pathway, offering a molecular explanation for neurodevelopmental disorders such as Huppke-Brindle Syndrome, characterized by severe intellectual disability and progressive neurodegeneration.

Huppke-Brindle Syndrome had previously been associated with mutations in the SLC33A1 gene, but the functional consequences remained poorly understood. This study links the pathology directly to disturbed glutathione homeostasis and protein folding impairment within the ER during critical stages of brain development. The authors postulate that therapeutic strategies aimed at modulating glutathione levels or transporter activity might mitigate disease progression in affected individuals.

Beyond neurological implications, the research extends to oncology, particularly tumors harboring mutations in the KEAP1 gene. Such cancers demonstrate heightened dependence on glutathione synthesis for survival and proliferation. By targeting SLC33A1 to manipulate glutathione export and accumulation within the ER, it may be possible to induce toxic oxidative imbalances selectively in cancer cells, thus offering a novel strategy for therapeutic intervention.

This discovery also exemplifies a broader principle in cell biology: the critical importance of metabolite and nutrient trafficking across organelle membranes in regulating cellular function and health. The characterization of transporters like SLC33A1 elucidates not only fundamental biochemical pathways but also reveals new classes of druggable proteins involved in disease pathogenesis.

The collaborative effort between Birsoy’s metabolic regulation group and Richard Hite’s structural biology lab was instrumental in resolving the biochemical features of the SLC33A1 transporter. High-resolution structural studies provided direct visualization of the transporter’s binding interactions with glutathione molecules, decoding the molecular basis for its specificity and kinetics. These insights establish a framework to design targeted molecules capable of modulating SLC33A1 activity.

The implications for future research are vast. The uncharted territory of organelle transporter biology holds promise for redefining our understanding of intracellular metabolic compartmentalization and the crosstalk between organelles like the ER and mitochondria. As the scientific community delves further into this area, additional transporters regulating other critical metabolites may be uncovered, broadening the landscape of potential therapeutic targets.

In summary, the Rockefeller team’s findings demonstrate how a single protein, SLC33A1, plays a gatekeeping role in maintaining the oxidative balance necessary for protein folding in the ER. This balance is essential to uphold cellular function and viability, and its disruption links to devastating human diseases. This work fixes a previously obscure piece of the puzzle regarding glutathione’s role in ER biology and offers tantalizing prospects for disease intervention through metabolic and molecular engineering.

The study not only enriches the fundamental biology of cellular homeostasis but also exemplifies the impact of combining innovative biochemical assays, genetic screenings, and structural biology to solve complex biological questions. By clarifying the molecular mechanisms by which the ER maintains its redox environment, these findings propel the field toward new therapeutic horizons in neurology and oncology.

As Birsoy remarks, understanding the transport systems governing metabolite exchange between cellular compartments is crucial. This study sets a precedent for investigating other transport proteins that may be central to diseases characterized by metabolic and proteostatic imbalance. Such knowledge will undoubtedly accelerate the translation of basic science into clinical breakthroughs.

This landmark research marks a significant advancement in cell biology, bridging molecular transport processes with disease pathology and therapeutic potential. It highlights the intricate interplay between redox chemistry, protein quality control, and cellular health—core principles that underlie the complexity of life itself.

Subject of Research: Glutathione transport regulation and redox homeostasis in the endoplasmic reticulum

Article Title: SLC33A1 exports oxidized glutathione to maintain endoplasmic reticulum redox homeostasis

News Publication Date: April 17, 2026

Web References: 10.1038/s41556-026-01922-y

Image Credits: Lori Chertoff / The Rockefeller University

Keywords: Antioxidants, Endoplasmic reticulum, Protein folding, Redox homeostasis, Glutathione transport, SLC33A1, Neurodegeneration, Cancer, Mitochondria, Cellular metabolism, Molecular transporters

Multiple myeloma, characterized by malignant proliferation of monoclonal plasma cells, frequently leads to the overproduction of immunoglobulin light chains. These light chains can misfold and aggregate, depositing as amyloid fibrils in various tissues—a pathological hallmark linked to organ dysfunction and poor prognosis. Despite decades of study, the precise molecular organization of amyloid fibrils derived from patient tissues remained elusive, confounding efforts to devise targeted therapies. This new study addresses that knowledge gap by harnessing state-of-the-art cryo-EM techniques to capture high-resolution structural snapshots of native light chain fibrils.

The research team meticulously isolated fibrils from the abdominal fat tissue, a minimally invasive biopsy site commonly utilized in amyloid detection, ensuring pathological relevance of the specimens studied. Using advanced cryo-EM imaging and reconstruction protocols, they resolved the fibril ultrastructure at near-atomic resolution, illuminating the conformational motifs responsible for light chain polymerization. This approach bypasses the limitations of recombinant fibrils formed in vitro, which often fail to recapitulate the complex heterogeneity observed in patient-derived amyloids.

Structurally, the light chain fibrils showcased a distinctive cross-β architecture—a hallmark of amyloids—composed of stacked β-strands oriented perpendicular to the fibril axis. The spatial arrangement revealed polymorphic variations reflecting distinct patient-specific light chain sequences, which influence the propensity for fibril assembly and tissue tropism. Key hydrophobic and charged residues were found to mediate interstrand stabilization via hydrogen bonding and salt bridges, providing a molecular rationale for amyloid stability and insidious persistence in vivo.

One of the most striking findings was the elucidation of “steric zipper” interfaces—precisely interdigitated side chains from adjacent β-sheets forming a dry, tightly packed core. These zipper-like contacts confer remarkable insolubility and resistance to proteolytic degradation, challenging conventional therapeutic modalities. Understanding the nature of these interfaces offers new avenues for designing small molecules or antibodies capable of disrupting fibril integrity by targeting these critical contact points.

Moreover, the cryo-EM maps enabled visualization of variable domain conformations within the fibrils, clarifying how patient-specific amino acid substitutions modify fibrillar morphology. These insights explain divergent clinical manifestations and progression rates among multiple myeloma patients afflicted with amyloidosis, highlighting the importance of precision medicine approaches tailored to fibril structure and sequence.

This research also unearthed evidence of post-translational modifications such as glycosylation and oxidation within the fibrillar proteins, factors hypothesized to promote aggregation kinetics or fibril stability. Capturing these modifications in situ enhances understanding of the pathological environment influencing amyloidogenesis and informs development of intervention strategies that can disrupt these biochemical processes.

Importantly, the direct extraction and imaging of fibrils from patient tissues circumvent artifact generation inherent in overexpression or synthetic fibril models. This establishes a new standard for structural amyloid biology, anchoring future studies in patient-relevant molecular conformations. The methodology demonstrates how advanced imaging synergized with clinical sampling can overcome limitations that historically impeded mechanistic insights in amyloid diseases.

By elucidating the atomic-level structure of light chain amyloid fibrils formed in vivo, this work bridges structural biology with clinical pathology and therapeutics. The detailed knowledge of fibril architecture paves the way for rational drug design targeting amyloid disruption or prevention. Potential strategies include molecules capable of capping growing fibril ends, destabilizing steric zippers, or inhibiting nucleation stages critical for fibril genesis.

Furthermore, understanding fibril polymorphism informs biomarker development to improve diagnosis and monitor therapeutic efficacy in multiple myeloma-associated amyloidosis. Structural signatures derived from cryo-EM data may enable imaging agent design or serum assays that detect specific fibril conformers correlating with patient prognosis or treatment response.

The implications extend beyond multiple myeloma since light chain amyloidosis shares pathological mechanisms with a spectrum of degenerative diseases involving amyloid fibril deposition. Comparative analyses enabled by this study’s cryo-EM maps can elucidate convergent and divergent principles of amyloid formation across protein families, enriching our general understanding of protein misfolding diseases.

This milestone exemplifies how technological breakthroughs in cryo-EM, coupled with sophisticated biochemical isolation from patient specimens, are revolutionizing structural medicine. As cryo-EM accessibility expands, applying similar workflows to other clinical amyloid presentations promises rapid advancement of personalized therapeutics targeting the root molecular causes.

In conclusion, through meticulous cryo-EM characterization of native light chain fibrils derived from multiple myeloma patients’ abdominal fat biopsies, scientists have charted uncharted molecular terrain that will undeniably influence both basic amyloid science and clinical management strategies. This fusion of structural detail with patient-specific pathology heralds a new era in conquering devastating amyloid diseases by illuminating precise molecular targets for future medicines.

Subject of Research: Cryo-electron microscopy structural analysis of light chain amyloid fibrils isolated from abdominal fat biopsies in multiple myeloma patients.

Article Title: Cryo-EM structures of light chain fibrils from abdominal fat biopsies of multiple myeloma patients.

Article References:
Yao, Y., Yao, S., Xu, Y. et al. Cryo-EM structures of light chain fibrils from abdominal fat biopsies of multiple myeloma patients. Nat Commun (2026). https://doi.org/10.1038/s41467-026-69784-4

Image Credits: AI Generated

The architecture of proteins underpins virtually every biological function, serving as essential molecular machines within cells that govern physiological processes. It is the precise three-dimensional conformation of these proteins that dictates their specific roles within living organisms. Even subtle deviations in protein folding can precipitate severe pathological conditions, underscoring the critical need for accurate structural elucidation in understanding disease mechanisms and therapeutic intervention.

Recent breakthroughs in artificial intelligence, especially through platforms like Google’s AlphaFold, have transformed the landscape of protein structure prediction by delivering remarkably precise models at an unprecedented scale. Despite their impressive capabilities, however, these AI tools do not guarantee uniform accuracy across the diverse spectrum of protein families and structural motifs. This inconsistency presents a significant barrier to widespread adoption and trust in predicted models as foundations for subsequent scientific and clinical applications.

PSBench addresses this crucial gap by furnishing an extensive benchmark collection comprising 1.4 million protein models, each rigorously annotated and independently assessed for quality. This curated dataset empowers researchers to develop, train, and validate new AI algorithms explicitly designed to estimate the fidelity of predicted protein structures. By embedding quality assessment into the AI modeling pipeline, scientists can more judiciously decide which predictions warrant confidence and further experimental scrutiny.

The genesis of PSBench traces back to the pioneering efforts of Jianlin “Jack” Cheng and his research team at the University of Missouri’s College of Engineering. Building upon decades of protein folding research and leveraging resources from the prestigious Critical Assessment of protein Structure Prediction (CASP), the team consolidated community-wide data to construct this comprehensive tool. CASP serves as an international gold standard competition, independently evaluating computational methods for protein structure prediction, providing a robust foundation for quality benchmarking.

Protein folding, an enigma that puzzled researchers for over half a century, was irrevocably transformed in 2012 when Cheng’s group demonstrated the power of deep learning in solving this complex problem. Their contributions sparked a paradigm shift within the field, inspiring subsequent AI models like AlphaFold and pushing the boundaries of computational biology. PSBench emerges as a direct continuation of this trajectory, seeking to democratize reliable protein quality assessment techniques worldwide.

At the recent Thirty-Ninth Annual Conference on Neural Information Processing Systems (NeurIPS 2025), Cheng alongside collaborators Jian Liu and Pawan Neupane presented the PSBench study, illuminating its potential to steer the next generation of AI-driven biomedical discovery. NeurIPS, renowned for spotlighting transformative AI innovations such as those integral to ChatGPT, provided a high-impact platform to unveil the dataset’s capabilities and foster cross-disciplinary collaboration.

Unlike existing repositories that predominantly focus on protein structure predictions, PSBench embeds quantitative quality metrics into each entry, creating a multifaceted landscape for both training and benchmarking AI-driven quality estimation models. This capability is particularly vital given the heterogeneity of protein folds, dynamic structural states, and the inherent challenges in experimentally resolving convoluted regions within large molecular assemblies.

The implications of PSBench extend far beyond academic exercises; by improving the reliability of predicted protein models, pharmaceutical researchers can streamline the pipeline of drug design. Accurate protein structures inform binding affinity simulations, facilitate the identification of promising drug candidates, and potentially reduce the time and cost of bringing new therapies to market. This is especially poignant in tackling neurodegenerative diseases like Alzheimer’s, where the pathophysiology is intricately linked to misfolded proteins.

Furthermore, PSBench fosters innovation in AI methodologies by offering a standardized dataset against which researchers can rigorously test novel algorithms. This helps ensure that improvements in predictive accuracy are objectively measurable, reproducible, and generalizable across a broad spectrum of proteins. Such standardized benchmarking is essential to maintain methodological rigor in the rapidly evolving intersection of AI and bioinformatics.

Cheng emphasizes that PSBench represents more than just a database; it is a strategic enabler for a new era of biomedical exploration where machine learning seamlessly integrates with molecular biology to unlock insights previously out of reach. Facilitating trust in computational models through robust quality assessment is a critical step toward integrating AI predictions into clinical and pharmaceutical decision-making frameworks.

In sum, the release of PSBench heralds a critical milestone in computational structural biology. By marrying massive-scale protein modeling with meticulous quality annotation, the University of Missouri researchers have empowered a global scientific community to transcend prior limitations in protein prediction confidence. This resource stands poised to accelerate breakthroughs across multiple domains, from fundamental life sciences research to the practical realities of drug development targeting some of the most intractable diseases affecting humanity today.

Subject of Research: Protein structure prediction, AI-driven quality assessment, drug development, biomedical research

Article Title: University of Missouri Unveils PSBench: The World’s Largest Annotated Protein Model Database to Revolutionize AI-driven Drug Discovery

News Publication Date: Not specified

Web References: Not specified

References: Not specified

Image Credits: Abbie Lankitus/University of Missouri

Keywords: Life sciences; Biochemistry; Proteins; Pharmacology; Drug development; Drug design; Drug candidates; Drug discovery; Protein functions; Protein structure; Computer science; Computer modeling; Three dimensional modeling; Health and medicine; Diseases and disorders; Cancer; Neurological disorders; Neurodegenerative diseases; Alzheimer disease; Protein folding; Protein activity; Artificial intelligence

The study, titled “Computational investigation of the sequence context of arginine/glycine-rich motifs in the human proteome,” presents a thorough computational analysis that enhances our molecular comprehension of how RG-rich motifs function. Through advanced bioinformatics techniques, the researchers meticulously mapped these motifs against a rich tapestry of protein sequences, revealing important associations that may have previously gone unnoticed. By employing multiple sequence alignments and structural predictions, they have offered fresh perspectives on how these motifs influence protein interactions and stability.

At the heart of this investigation lies a critical challenge in biological research: understanding the role of non-coding sequences in the human genome and their impact on the functionality of proteins. The research team employed sophisticated computational models designed to analyze not only the motifs themselves but also their sequence neighbors. They aimed to unravel the sophisticated coding patterns that determine how these motifs behave within different proteins and cellular contexts.

The results from this extensive computational research illuminate the delicate balance within protein structures. The masterful interplay between RG-rich motifs and their sequence contexts provides insights into protein folding dynamics, thus influencing cellular responses under various physiological conditions. This aspect is particularly critical when considering the implications for diseases that arise from dysfunctional protein interactions, including neurodegenerative disorders and various types of cancers which are often linked to misregulated protein motility and expression.

One of the primary methodologies utilized in this study involved high-throughput data mining from existing genomic databases. By aggregating data from various sources, the researchers were able to construct a comprehensive profile of RG-rich motifs basking amidst an ocean of human protein sequences. This computational approach not only expedites the identification of novel motifs but also reveals evolutionary patterns, serving as a time capsule of biological history hidden within the folds of proteins.

Moreover, the authors took advantage of machine learning techniques to enhance the predictive accuracy of their models. This integration of artificial intelligence tools signifies a paradigm shift in computational biology where predictive analytics can effectively anticipate motifs’ functional capabilities based on their contextual environments. The foresight offered by these advanced methodologies is pivotal for preemptively identifying potential therapeutic targets essential for drug development.

In viewing these motifs through an evolutionary lens, the study posits that RG-rich motifs have been conserved across many species, indicating their fundamental importance in biological systems. The researchers trace the evolutionary lineage, noting that understanding the conservation of these sequences can provide valuable insights into the mechanisms of protein evolution and the functionality underlying specific protein interactions. This has profound implications for evolutionary biology, as well as for therapeutic developments in disorders characterized by protein aggregation.

The study highlights several specific examples where RG-rich motifs have been implicated in key cellular mechanisms. For instance, these motifs are essential in forming complexes with RNA, influencing gene expression regulation. The implications of this are vast, as many biological processes are tightly regulated by RNA-binding proteins, which rely on these motifs to execute their functions. The paper discusses how aberrations in these motifs can lead to miscommunication within the cellular machinery, underscoring their importance.

In addition to their biological significance, the structural implications of RG-rich motifs are noteworthy. The researchers examined the three-dimensional conformations that these motifs can adopt, presenting a comprehensive view of protein folding. This structural insight is critical for understanding how proteins maintain their stability in the cellular milieu, and how they can sometimes fall prey to aggregation, a hallmark of many neurological diseases such as Alzheimer’s.

The findings reported by Schumbera and colleagues have spurred a wave of curiosity within the scientific community. The notion that these motifs play multifaceted roles prompts further inquiry into whether targeting these regions with small molecules could ameliorate diseases associated with protein aggregation. The paper lays the groundwork for future research endeavors that might yield novel therapeutic strategies aimed at modulating the functionality of RG-rich motifs.

As researchers continue to delve into the intricate world of the human proteome, this study serves as a timely reminder of the sophistication within biological systems. The computational investigations shed light on aspects of protein functionality that have long been overlooked, driving home the idea that the human genome harbors vast reservoirs of untapped knowledge waiting to be uncovered.

In conclusion, the detailed computational investigation into arginine/glycine-rich motifs signals a significant milestone in genomic research. The interactions of these motifs within their sequence context offer key insights into protein behavior and cellular processes that extend far beyond mere protein mechanics. This study is poised to illuminate new paths in bioscience, impacting various fields from molecular biology to therapeutic drug design. The journey into the depths of the human proteome is just beginning, and this work stands as a beacon guiding the way forward.

Subject of Research: Arginine/Glycine-rich motifs in human proteome.

Article Title: Computational investigation of the sequence context of arginine/glycine-rich motifs in the human proteome.

Article References:

Schumbera, E., Dormann, D., Walther, A. et al. Computational investigation of the sequence context of arginine/glycine-rich motifs in the human proteome. BMC Genomics 26, 883 (2025). https://doi.org/10.1186/s12864-025-12132-5

Image Credits: AI Generated

DOI: 10.1186/s12864-025-12132-5

Keywords: arginine/glycine-rich motifs, human proteome, protein structure, computational biology, disease mechanisms, RNA binding, protein interactions, bioinformatics.

Proteins are synthesized as linear chains of amino acids that must fold precisely into their native conformations to function correctly. Misfolded proteins not only fail to perform their biological roles but can also aggregate and trigger diseases such as diabetes, neurodegenerative disorders, and other protein misfolding pathologies. Cellular quality control mechanisms have traditionally focused on chaperone proteins, molecular assistants that facilitate folding by transiently binding to nascent or misfolded polypeptides. Until now, these chaperones were thought to operate individually, diffusing through the lumen of the endoplasmic reticulum (ER) to intercept and guide proteins. However, the Basel team’s research paints a strikingly different picture: chaperones dynamically self-organize into highly concentrated, droplet-like condensates that act as dedicated protein folding hubs.

These condensates, driven by multivalent interactions among chaperone molecules, form phase-separated microenvironments within the ER. The study highlights the pivotal role of PDIA6, a specific protein disulfide isomerase family member, which initiates the assembly of these condensates by engaging in homotypic interactions. Once established, these condensates recruit a diverse repertoire of chaperones, generating localized hotspots with concentrated folding capacity. Such spatial organization dramatically enhances the efficiency and fidelity of protein folding, as unfolded or misfolded polypeptides are effectively funneled into these condensates, folded correctly, and subsequently released back into the ER for transport to their cellular destinations.

The implications of these findings transcend basic cell biology, as defects in this system can have profound pathological consequences. Genetic mutations identified in PDIA6 in families affected by conditions including liver fibrosis, diabetes, and cognitive deficits suggest that impaired condensate formation disrupts proteostasis, leading to aberrant folding and accumulation of misfolded proteins. Functional analyses revealed that proinsulin—the precursor to the critical glucose-regulating hormone insulin—depends heavily on these chaperone condensates for correct folding. Mutant cells deficient in PDIA6 failed to form condensates adequately, resulting in diminished insulin synthesis and secretion, a molecular pathology consistent with diabetic phenotypes observed in patients.

At the mechanistic level, the formation of these condensates represents a form of biological phase separation—the assembly of membrane-less organelles via weak, multivalent interactions among proteins. Such condensates provide cells with a versatile strategy for organizing biochemical reactions in space and time, enriching reaction partners, and sequestering substrates. The high local concentration of chaperones within these droplets creates a favorable environment for efficient protein folding and quality control, preventing the aggregation of unfolded protein species that are typically implicated in neurodegeneration and other disorders.

The discovery also demands a reevaluation of how the ER and potentially other organelles are conceptualized within cell biology. Traditionally viewed as relatively homogeneous compartments, the ER now appears to harbor intricate microdomains specialized for discrete biochemical functions, including these newly identified chaperone condensates. This advances our understanding of intracellular organization, suggesting that phase separation is a broadly utilized principle for regulating cellular processes, extending from gene expression to signal transduction and proteostasis.

Moreover, this study serves as a conceptual and practical springboard for the development of novel therapeutic interventions. By targeting the molecular interactions that govern condensate formation or stability, it may be possible to correct or enhance protein folding capacity in cells burdened by misfolding diseases. Such approaches hold promise for combatting a spectrum of ailments, from diabetes and cystic fibrosis to neurodegenerative and certain cancers, where protein misfolding and aggregation constitute central pathogenic mechanisms.

The methodology employed combined cutting-edge cell biology, biophysics, and structural biology techniques to characterize the properties and dynamics of chaperone condensates. Employing fluorescence microscopy, the team visualized these droplets within live cells, while biochemical assays elucidated their composition and recruitment dynamics. Mutagenesis of PDIA6 underscored its indispensable role in condensate nucleation, and functional assays linked condensate integrity to cellular viability and secretory competence, particularly pertinent in pancreatic β-cells responsible for insulin production.

Importantly, the research contextualizes these findings within a broader physiological framework. Cellular stress conditions, such as those encountered during inflammation or metabolic imbalance, often overwhelm folding systems. The presence of chaperone condensates may serve as a buffering mechanism, ensuring proteostasis is maintained despite fluctuating demands or environmental challenges. Their failure precipitates chronic ER stress and activation of maladaptive pathways, ultimately culminating in cell death, organ dysfunction, and disease.

This revelation breathes new life into the field of protein homeostasis and demands a shift in therapeutic perspectives. Rather than focusing solely on individual chaperones or misfolded proteins, interventions may benefit from strategies that restore or mimic the organizational framework provided by condensates. Artificially engineered condensates or small molecules modulating phase separation dynamics could become innovative tools to counteract protein misfolding diseases.

In conclusion, the identification of multi-chaperone condensates fundamentally redefines our comprehension of protein folding within the cellular milieu. These “folding factories” operate as highly specialized, self-organizing hubs within the ER, leveraging phase separation to amplify the cell’s capacity for precise and efficient protein maturation. Their significance extends from molecular mechanistic insights to translational medicine, heralding a new frontier in the fight against a host of debilitating diseases rooted in proteostasis failure. As the biomedical community embraces this paradigm, further research will undoubtedly unravel the diverse regulatory networks governing condensate biology and their far-reaching implications for health and disease.

Subject of Research: Protein folding, chaperone condensates, endoplasmic reticulum organization

Article Title: A multi-chaperone condensate enhances protein folding in the endoplasmic reticulum.

News Publication Date: 11-Aug-2025

Web References: 10.1038/s41556-025-01730-w

Image Credits: Biozentrum, University of Basel

Keywords: Biochemistry, Protein folding, Structural biology, Molecular biology, Cell biology